1. Home
  2. RDHL vs SOPA Comparison

RDHL vs SOPA Comparison

Compare RDHL & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • SOPA
  • Stock Information
  • Founded
  • RDHL 2009
  • SOPA 2018
  • Country
  • RDHL Israel
  • SOPA Singapore
  • Employees
  • RDHL N/A
  • SOPA N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • SOPA EDP Services
  • Sector
  • RDHL Health Care
  • SOPA Technology
  • Exchange
  • RDHL Nasdaq
  • SOPA Nasdaq
  • Market Cap
  • RDHL 3.9M
  • SOPA 3.8M
  • IPO Year
  • RDHL N/A
  • SOPA 2021
  • Fundamental
  • Price
  • RDHL $1.23
  • SOPA $1.20
  • Analyst Decision
  • RDHL
  • SOPA Strong Buy
  • Analyst Count
  • RDHL 0
  • SOPA 1
  • Target Price
  • RDHL N/A
  • SOPA $15.00
  • AVG Volume (30 Days)
  • RDHL 1.4M
  • SOPA 51.4K
  • Earning Date
  • RDHL 08-28-2025
  • SOPA 08-18-2025
  • Dividend Yield
  • RDHL N/A
  • SOPA N/A
  • EPS Growth
  • RDHL N/A
  • SOPA N/A
  • EPS
  • RDHL N/A
  • SOPA N/A
  • Revenue
  • RDHL $8,042,999.00
  • SOPA $6,731,955.00
  • Revenue This Year
  • RDHL $381.91
  • SOPA N/A
  • Revenue Next Year
  • RDHL N/A
  • SOPA $45.16
  • P/E Ratio
  • RDHL N/A
  • SOPA N/A
  • Revenue Growth
  • RDHL 23.17
  • SOPA N/A
  • 52 Week Low
  • RDHL $1.17
  • SOPA $0.64
  • 52 Week High
  • RDHL $15.34
  • SOPA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 33.65
  • SOPA 44.13
  • Support Level
  • RDHL $1.17
  • SOPA $1.11
  • Resistance Level
  • RDHL $3.31
  • SOPA $1.29
  • Average True Range (ATR)
  • RDHL 0.31
  • SOPA 0.06
  • MACD
  • RDHL -0.09
  • SOPA -0.01
  • Stochastic Oscillator
  • RDHL 2.80
  • SOPA 38.02

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

Share on Social Networks: